Literature DB >> 34766779

Total Synthesis of (-)-Kopsifoline A and (+)-Kopsifoline E.

In-Soo Myeong1, Nadide Hazal Avci1, Mohammad Movassaghi1.   

Abstract

We report the first total synthesis of (-)-kopsifoline A and (+)-kopsifoline E. Our synthetic strategy features a biogenetically inspired regioselective C17-functionalization of a versatile intermediate containing the pentacyclic core of aspidosperma alkaloids. The vinylogous urethane substructure of this intermediate affords (-)-kopsifoline D via C3-C21 bond formation under the Mitsunobu reaction conditions, while it enables selective C17-functionalization en route to (-)-kopsifoline A and (+)-kopsifoline E.

Entities:  

Mesh:

Year:  2021        PMID: 34766779      PMCID: PMC9048213          DOI: 10.1021/acs.orglett.1c03448

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.072


  55 in total

1.  Total synthesis, stereochemical assignment, and biological activity of all known (-)-trigonoliimines.

Authors:  Sunkyu Han; Karen C Morrison; Paul J Hergenrother; Mohammad Movassaghi
Journal:  J Org Chem       Date:  2013-10-31       Impact factor: 4.354

2.  A Desymmetrization-Based Total Synthesis of Reserpine.

Authors:  Jisook Park; David Y-K Chen
Journal:  Angew Chem Int Ed Engl       Date:  2018-11-08       Impact factor: 15.336

3.  Remarkably Efficient Iridium Catalysts for Directed C(sp2)-H and C(sp3)-H Borylation of Diverse Classes of Substrates.

Authors:  Md Emdadul Hoque; Mirja Md Mahamudul Hassan; Buddhadeb Chattopadhyay
Journal:  J Am Chem Soc       Date:  2021-03-30       Impact factor: 15.419

4.  Remarkably selective iridium catalysts for the elaboration of aromatic C-H bonds.

Authors:  Jian-Yang Cho; Man Kin Tse; Daniel Holmes; Robert E Maleczka; Milton R Smith
Journal:  Science       Date:  2001-11-22       Impact factor: 47.728

5.  Concise total synthesis and stereochemical revision of all (-)-trigonoliimines.

Authors:  Sunkyu Han; Mohammad Movassaghi
Journal:  J Am Chem Soc       Date:  2011-06-20       Impact factor: 15.419

6.  Iridium-catalyzed C-H borylation of pyridines.

Authors:  Scott A Sadler; Hazmi Tajuddin; Ibraheem A I Mkhalid; Andrei S Batsanov; David Albesa-Jove; Man Sing Cheung; Aoife C Maxwell; Lena Shukla; Bryan Roberts; David C Blakemore; Zhenyang Lin; Todd B Marder; Patrick G Steel
Journal:  Org Biomol Chem       Date:  2014-10-07       Impact factor: 3.876

7.  Pd-catalyzed C-H oxygenation with TFA/TFAA: expedient access to oxygen-containing heterocycles and late-stage drug modification.

Authors:  Gang Shan; Xinglin Yang; Linlin Ma; Yu Rao
Journal:  Angew Chem Int Ed Engl       Date:  2012-11-19       Impact factor: 15.336

8.  A concise and versatile double-cyclization strategy for the highly stereoselective synthesis and arylative dimerization of Aspidosperma alkaloids.

Authors:  Jonathan William Medley; Mohammad Movassaghi
Journal:  Angew Chem Int Ed Engl       Date:  2012-03-12       Impact factor: 15.336

9.  Functional group directed C-H borylation.

Authors:  A Ros; R Fernández; J M Lassaletta
Journal:  Chem Soc Rev       Date:  2014-02-20       Impact factor: 54.564

10.  Total Syntheses of (-)-Deoxoapodine, (-)-Kopsifoline D, and (-)-Beninine.

Authors:  Yi-Guo Zhou; Henry N C Wong; Xiao-Shui Peng
Journal:  J Org Chem       Date:  2019-12-26       Impact factor: 4.354

View more
  3 in total

1.  Total Synthesis of (-)-Kopsifoline A and (+)-Kopsifoline E.

Authors:  In-Soo Myeong; Nadide Hazal Avci; Mohammad Movassaghi
Journal:  Org Lett       Date:  2021-11-12       Impact factor: 6.072

2.  Total Synthesis of (-)-Voacinol and (-)-Voacandimine C.

Authors:  Kristen M Flynn; In-Soo Myeong; Taylor Pinto; Mohammad Movassaghi
Journal:  J Am Chem Soc       Date:  2022-05-11       Impact factor: 16.383

3.  Semi-syntheses and interrogation of indole-substituted Aspidosperma terpenoid alkaloids.

Authors:  Jinfeng Kang; Todd R Lewis; Alex Gardner; Rodrigo B Andrade; Rongsheng E Wang
Journal:  Org Biomol Chem       Date:  2022-05-18       Impact factor: 3.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.